JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
MKTX
MarketAxess Holdings Inc.
MKTX has the edge over JPM overall, supported by stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MKTX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MKTX's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MKTX.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MKTX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 20x | $165 | — |
| Forward | 20x | $165 | — |
| Cheap | 29x | $238 | +44% |
| Fair | 40x | $328 | +99% |
| Expensive | 66x | $535 | +224% |
Historical ranges are pointers, not guarantees.
MKTX has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over MKTX on the outlook, with more favorable revenue expectations.
MKTX Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect MKTX's earnings to grow and its profitability to improve, with its revenue holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MKTX on earnings, with more consistent year-over-year improvement.
MKTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.43 | +3.4% |
| Q3 2026 | $8.15 | +38% |
| Q2 2026 | $8.46 | +42% |
| Q1 2026 | $8.44 | +47% |
| Q4 2025 | $6.64 | -8.8% |
| Q3 2025 | $5.89 | -20% |
| Q2 2025 | $5.95 | -14% |
| Q1 2025 | $5.76 | -15% |
| Q4 2024 | $7.28 | +6.3% |
MKTX earned $8.15 per share over the past year, up 38% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over MKTX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MKTX on profitability, with a higher operating margin.
MKTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $210.4M | +0.8% |
| Q2 2026 | $218.4M | -0.5% |
| Q1 2026 | $233.4M | +12% |
| Q4 2025 | $209.4M | +3.5% |
| Q3 2025 | $208.8M | +1% |
| Q2 2025 | $219.5M | +11% |
| Q3 2022 | $172.1M | +6.2% |
| Q2 2022 | $182.2M | +3.3% |
MKTX's revenue has held roughly level: $210M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | -5.6 points |
| Q2 2026 | 41% | -0.7 points |
| Q1 2026 | 43% | +0.9 points |
| Q4 2025 | 36% | -3.2 points |
| Q3 2025 | 41% | -1.1 points |
| Q2 2025 | 42% | +0.7 points |
| Q1 2025 | 42% | N/A |
| Q4 2024 | 40% | N/A |
MKTX's operating margin was 35% last quarter, down 5.6 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MKTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $246.7M | +178% |
| Q2 2026 | $26.2M | -74% |
| Q1 2026 | -$75.6M | -373% |
| Q4 2025 | $155.1M | -12% |
| Q3 2025 | $88.7M | -5.9% |
| Q2 2025 | $102.5M | -7.8% |
| Q1 2025 | $27.7M | +$33.8M |
| Q4 2024 | $176M | +26% |
MKTX has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MKTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +36K shares |
| 1 year | -4.9% | -1.8M shares |
| 3 years | -6.1% | -2.3M shares |
| 5 years | -7.4% | -2.8M shares |
| Available history | -7.1% | -2.7M shares |
MKTX has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $300M |
| Q3 2025 | $45.3M |
| Q2 2025 | $36.7M |
| Q1 2025 | $38.1M |
| Q4 2024 | $16.8M |
MKTX spent $300M buying back its own shares over the past year, up 119% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MKTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
MKTX has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MKTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.8 | Neutral |
| Stochastic | 93.0 | Overbought |
MKTX's weekly RSI is 60 (neutral) and its Stochastic is 93 (overbought).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over MKTX on valuation relative to its sector.
MKTX PE vs Financial Services Sector
| Metric | MKTX | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 56% above |
| PE % | 7 | 63 | 56 pts below |
MKTX is trading at 20x earnings, a 56% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MKTX on trend strength, trading above more of its moving averages.
MKTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $164.8 | 0.2% above |
| 20 week MA | $154.1 | 7.2% above |
| 50 week MA | $158.5 | 4.2% above |
| 100 week MA | $180.6 | 8.5% below |
| 200 week MA | $219.8 | 25% below |
MKTX has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 25% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MKTX on returns for 2026, with the stronger performance.
MKTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $375.0 | $573.1 | +53% |
| 2021 | $573.1 | $410.7 | -28% |
| 2022 | $410.7 | $280.9 | -32% |
| 2023 | $280.9 | $292.9 | +4.3% |
| 2024 | $292.9 | $229.0 | -22% |
| 2025 | $229.0 | $182.9 | -20% |
| 2026 YTD | $182.9 | $165.2 | -9.7% |
MKTX has finished lower in four of the last six years. It's down 9.7% so far in 2026.